Painful Diabetic Neuropathy
📧 Sign up to get email alerts when something new happens for Painful Diabetic Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-11-28Clinical Trial Update: Efficacy and Safety of VM202 in Painful Diabetic Peripheral Neuropathy -The HOPES Trial [Phase 2]
The HOPES trial assessed VM202 for painful diabetic neuropathy in Phase 2 and has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-26Clinical Trial Update: Clinical Trial Designed to Determine the Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy [Phase 2]
The Phase 2 trial of EMA401 for painful diabetic neuropathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-07-27Clinical Trial Update: A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115) [Phase 2]
A Phase 2 clinical trial investigating a single-dose pain therapy for Painful Diabetic Neuropathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-02-25Clinical Trial Update: Safety and Efficacy Study of BC-DN-01 in Painful Diabetic Peripheral Neuropathy [Phase 1, Phase 2]
A Phase 1/2 safety and efficacy study of BC-DN-01 for painful diabetic peripheral neuropathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-11-12Clinical Trial Update: A Clinical Trial to Study the Effects of GRC 17536 in Patients With Painful Diabetic Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients) [Phase 2]
Phase 2 trial investigating GRC 17536 for Painful Diabetic Neuropathy was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.